Altered Intracellular Signaling Associated with Dopamine D2 Receptor in the Prefrontal Cortex in Wistar Kyoto Rats

Wistar-Kyoto rats (WKY), compared to Wistar rats, are a well-validated animal model for drug-resistant depression. Thanks to this, they can provide information on the potential mechanisms of treatment-resistant depression. Since deep brain stimulation in the prefrontal cortex has been shown to produce rapid antidepressant effects in WKY rats, we focused our study on the prefrontal cortex. Using quantitative autoradiography, we observed a decrease in the binding of [3H] methylspiperone to the dopamine D2 receptor, specifically in that brain region—but not in the striatum, nor the nucleus accumbens—in WKY rats. Further, we focused our studies on the expression level of several components associated with canonical (G proteins), as well as non-canonical, D2-receptor-associated intracellular pathways (e.g., βarrestin2, glycogen synthase kinase 3 beta—Gsk-3β, and β-catenin). As a result, we observed an increase in the expression of mRNA encoding the regulator of G protein signaling 2-RGS2 protein, which is responsible, among other things, for internalizing the D2 dopamine receptor. The increase in RGS2 expression may therefore account for the decreased binding of the radioligand to the D2 receptor. In addition, WKY rats are characterized by the altered signaling of genes associated with the dopamine D2 receptor and the βarrestin2/AKT/Gsk-3β/β-catenin pathway, which may account for certain behavioral traits of this strain and for the treatment-resistant phenotype.

[1]  A. Faron-Górecka,et al.  Habenula as a Possible Target for Treatment-Resistant Depression Phenotype in Wistar Kyoto Rats , 2022, Molecular Neurobiology.

[2]  M. Papp,et al.  Genomic Screening of Wistar and Wistar-Kyoto Rats Exposed to Chronic Mild Stress and Deep Brain Stimulation of Prefrontal Cortex , 2019, Neuroscience.

[3]  A. Phillips,et al.  Evaluation of the Wistar-Kyoto rat model of depression and the role of synaptic plasticity in depression and antidepressant response , 2019, Neuroscience & Biobehavioral Reviews.

[4]  M. Papp,et al.  Validation of chronic mild stress in the Wistar-Kyoto rat as an animal model of treatment-resistant depression , 2019, Behavioural pharmacology.

[5]  M. Papp,et al.  The role of prefrontal cortex dopamine D2 and D3 receptors in the mechanism of action of venlafaxine and deep brain stimulation in animal models of treatment-responsive and treatment-resistant depression , 2019, Journal of psychopharmacology.

[6]  M. Kuśmider,et al.  Understanding GPCR dimerization. , 2019, Methods in cell biology.

[7]  Tengfei Ma,et al.  Dopamine D1 or D2 receptor‐expressing neurons in the central nervous system , 2018, Addiction biology.

[8]  A. Howlett,et al.  RGS2 modulates the activity and internalization of dopamine D2 receptors in neuroblastoma N2A cells , 2016, Neuropharmacology.

[9]  R. Servatius,et al.  Exposure to morphine-associated cues increases mu opioid receptor mRNA expression in the nucleus accumbens of Wistar Kyoto rats , 2016, Behavioural Brain Research.

[10]  R. Gaillard,et al.  The role of GSK-3 in treatment-resistant depression and links with the pharmacological effects of lithium and ketamine: A review of the literature. , 2016, L'Encephale.

[11]  C. Wotjak,et al.  Glycogen synthase kinase-3β inhibition in the medial prefrontal cortex mediates paradoxical amphetamine action in a mouse model of ADHD , 2015, Front. Behav. Neurosci..

[12]  S. Clinton,et al.  Learned helplessness and social avoidance in the Wistar-Kyoto rat , 2014, Front. Behav. Neurosci..

[13]  M. Bauer,et al.  Role of Lithium Augmentation in the Management of Major Depressive Disorder , 2014, CNS Drugs.

[14]  K. Martemyanov,et al.  Macromolecular Composition Dictates Receptor and G Protein Selectivity of Regulator of G Protein Signaling (RGS) 7 and 9-2 Protein Complexes in Living Cells* , 2013, The Journal of Biological Chemistry.

[15]  V. Russell,et al.  The spontaneously hypertensive and Wistar Kyoto rat models of ADHD exhibit sub-regional differences in dopamine release and uptake in the striatum and nucleus accumbens , 2012, Neuropharmacology.

[16]  B. Sabatini,et al.  Dopaminergic Modulation of Synaptic Transmission in Cortex and Striatum , 2012, Neuron.

[17]  Huaning Wang,et al.  The effect of citalopram on chronic stress-induced depressive-like behavior in rats through GSK3β/β-catenin activation in the medial prefrontal cortex , 2012, Brain Research Bulletin.

[18]  M. Furuse,et al.  Hypothesis with abnormal amino acid metabolism in depression and stress vulnerability in Wistar Kyoto rats , 2012, Amino Acids.

[19]  J. Beaulieu,et al.  Molecular Neuroscience Review Article Gsk-3 and Wnt Signaling in Neurogenesis and Bipolar Disorder , 2022 .

[20]  T. Sagvolden,et al.  Rat models of ADHD. , 2011, Current topics in behavioral neurosciences.

[21]  E. Kandel,et al.  D2 receptor overexpression in the striatum leads to a deficit in inhibitory transmission and dopamine sensitivity in mouse prefrontal cortex , 2011, Proceedings of the National Academy of Sciences.

[22]  B. O'dowd,et al.  The Dopamine D1–D2 Receptor Heteromer in Striatal Medium Spiny Neurons: Evidence for a Third Distinct Neuronal Pathway in Basal Ganglia , 2011, Front. Neuroanat..

[23]  Julia C. Lemos,et al.  Stress-Hyperresponsive WKY Rats Demonstrate Depressed Dorsal Raphe Neuronal Excitability and Dysregulated CRF-Mediated Responses , 2011, Neuropsychopharmacology.

[24]  R. Gainetdinov,et al.  The Physiology, Signaling, and Pharmacology of Dopamine Receptors , 2011, Pharmacological Reviews.

[25]  G. Forster,et al.  Central monoamine levels differ between rat strains used in studies of depressive behavior , 2010, Brain Research.

[26]  S. Hauser,et al.  Alcohol-induced depressive-like behavior is associated with cortical norepinephrine reduction , 2010, Pharmacology Biochemistry and Behavior.

[27]  J. Sweatt,et al.  Deficiency in the Inhibitory Serine-Phosphorylation of Glycogen Synthase Kinase-3 Increases Sensitivity to Mood Disturbances , 2010, Neuropsychopharmacology.

[28]  S. Faraone,et al.  Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type , 2010, Neuroscience.

[29]  Espen Borgå Johansen,et al.  The spontaneously hypertensive rat model of ADHD – The importance of selecting the appropriate reference strain , 2009, Neuropharmacology.

[30]  H. Dohlman.  RGS proteins the early days. , 2009, Progress in molecular biology and translational science.

[31]  F. Middleton,et al.  Behavioral and genetic evidence for a novel animal model of Attention-Deficit/Hyperactivity Disorder Predominantly Inattentive Subtype , 2008, Behavioral and Brain Functions.

[32]  Andrew M. Novick,et al.  Strain differences in the expression of dopamine D1 receptors in Wistar-Kyoto (WKY) and Wistar rats. , 2008, Life sciences.

[33]  J. Girault,et al.  Opposing Patterns of Signaling Activation in Dopamine D1 and D2 Receptor-Expressing Striatal Neurons in Response to Cocaine and Haloperidol , 2008, The Journal of Neuroscience.

[34]  Jason B. Tanenbaum,et al.  Wistar Kyoto and Wistar rats differ in the affective and locomotor effects of nicotine , 2008, Physiology & Behavior.

[35]  X. Jiao,et al.  Strain differences in the distribution of dopamine (DA-2 and DA-3) receptor sites in rat brain. , 2006, Life sciences.

[36]  T. Sotnikova,et al.  An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior , 2005, Cell.

[37]  R. Jope.  Inhibition of glycogen synthase kinase-3: a potential therapeutic target of lithium , 2004, Clinical Neuroscience Research.

[38]  R. D. L. Garza,et al.  A distinct neurochemical profile in WKY rats at baseline and in response to acute stress: implications for animal models of anxiety and depression , 2004, Brain Research.

[39]  J. Woodgett,et al.  Glycogen Synthase Kinase-3β Haploinsufficiency Mimics the Behavioral and Molecular Effects of Lithium , 2004, The Journal of Neuroscience.

[40]  Abraham Weizman,et al.  Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on β-catenin in mouse hippocampus , 2004, Biological Psychiatry.

[41]  R. Jope.  Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. , 2003, Trends in pharmacological sciences.

[42]  W. Paré,et al.  Strain differences in the distribution of dopamine transporter sites in rat brain , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[43]  H. Dohlman,et al.  RGS proteins: G protein-coupled receptors meet their match. , 2003, Assay and drug development technologies.

[44]  K. Proulx,et al.  Comparisons of Behavioral and Neurochemical Characteristics between WKY, WKHA, and Wistar Rat Strains , 2002, Neuropsychopharmacology.

[45]  I. Lucki,et al.  Amplified behavioral and endocrine responses to forced swim stress in the Wistar–Kyoto rat , 2002, Psychoneuroendocrinology.

[46]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[47]  K. Druey,et al.  Inhibition of regulator of G protein signaling function by two mutant RGS4 proteins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[48]  P. Willner.  The mesolimbic dopamine system as a target for rapid antidepressant action , 1997, International clinical psychopharmacology.

[49]  J. Thorner,et al.  RGS Proteins and Signaling by Heterotrimeric G Proteins* , 1997, The Journal of Biological Chemistry.

[50]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .